Recombinant human tissue kallikrein
DM199-2016-001
Phase 1 small_molecule completed
Quick answer
Recombinant human tissue kallikrein for Stroke is a Phase 1 program (small_molecule) at DiaMedica Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- DiaMedica Therapeutics
- Indication
- Stroke
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed